191 related articles for article (PubMed ID: 38292405)
41. Elevated interleukin 8 and matrix metalloproteinase 9 levels are associated with myocardial pathology in users of Anabolic-Androgenic Steroids.
Gregersen I; Scarth ME; Abdullah R; Thorsby PM; Hauger LE; Haugaa KH; Sagen EL; Michelsen AE; Ueland T; Edvardsen T; Aukrust P; Almaas VM; Bjørnebekk AK; Halvorsen B
Eur J Prev Cardiol; 2024 Apr; ():. PubMed ID: 38573232
[TBL] [Abstract][Full Text] [Related]
42. Toxic effects of anabolic-androgenic steroids in primary rat hepatic cell cultures.
Welder AA; Robertson JW; Melchert RB
J Pharmacol Toxicol Methods; 1995 Aug; 33(4):187-95. PubMed ID: 8527826
[TBL] [Abstract][Full Text] [Related]
43. Anabolic steroids and male infertility: a comprehensive review.
de Souza GL; Hallak J
BJU Int; 2011 Dec; 108(11):1860-5. PubMed ID: 21682835
[TBL] [Abstract][Full Text] [Related]
44. Supra-physiological doses of anabolic androgenic steroids impact erythropoietin and blood parameters.
Heiland CE; Schickel Y; Lehtihet M; Börjesson A; Ekström L
Drug Test Anal; 2023 Jun; 15(6):599-604. PubMed ID: 36730044
[TBL] [Abstract][Full Text] [Related]
45. Psychopathology among anabolic-androgenic steroid using and non-using female athletes in Norway.
Scarth M; Jørstad ML; Reierstad A; Klonteig S; Torgersen S; Hullstein IR; Bjørnebekk A
J Psychiatr Res; 2022 Nov; 155():295-301. PubMed ID: 36170757
[TBL] [Abstract][Full Text] [Related]
46. A review of the chemistry, biological action, and clinical applications of anabolic-androgenic steroids.
Shahidi NT
Clin Ther; 2001 Sep; 23(9):1355-90. PubMed ID: 11589254
[TBL] [Abstract][Full Text] [Related]
47. Clustering psychopathology in male anabolic-androgenic steroid users and nonusing weightlifters.
Jørstad ML; Scarth M; Torgersen S; Pope HG; Bjørnebekk A
Brain Behav; 2023 Jul; 13(7):e3040. PubMed ID: 37150843
[TBL] [Abstract][Full Text] [Related]
48. Carotid intima media thickness as a marker of increased cardiovascular risk due to androgenic anabolic steroids in male bodybuilders: a cross-sectional study.
Karagun B
J Sports Med Phys Fitness; 2024 Mar; 64(3):311-317. PubMed ID: 38213269
[TBL] [Abstract][Full Text] [Related]
49. Do anabolic-androgenic steroids have performance-enhancing effects in female athletes?
Huang G; Basaria S
Mol Cell Endocrinol; 2018 Mar; 464():56-64. PubMed ID: 28711608
[TBL] [Abstract][Full Text] [Related]
50. Can conditions of skeletal muscle loss be improved by combining exercise with anabolic-androgenic steroids? A systematic review and meta-analysis of testosterone-based interventions.
Falqueto H; Júnior JLR; Silvério MNO; Farias JCH; Schoenfeld BJ; Manfredi LH
Rev Endocr Metab Disord; 2021 Jun; 22(2):161-178. PubMed ID: 33783694
[TBL] [Abstract][Full Text] [Related]
51. Hidden Danger of Irrational Abusing Illegal Androgenic-anabolic Steroids in Recreational Athletes Age Under 35 in Bosnia & Herzegovina.
Solakovic S; Totic D; Vukas H; Djedovic M
Med Arch; 2015 Jun; 69(3):200-2. PubMed ID: 26261392
[TBL] [Abstract][Full Text] [Related]
52. Anabolic-Androgenic Steroid Abuse among Gym Users, Eastern Province, Saudi Arabia.
Albaker W; Alkhars A; Elamin Y; Jatoi N; Boumarah D; Al-Hariri M
Medicina (Kaunas); 2021 Jul; 57(7):. PubMed ID: 34356984
[No Abstract] [Full Text] [Related]
53. Anabolic androgenic steroid use is associated with ventricular dysfunction on cardiac MRI in strength trained athletes.
Luijkx T; Velthuis BK; Backx FJ; Buckens CF; Prakken NH; Rienks R; Mali WP; Cramer MJ
Int J Cardiol; 2013 Aug; 167(3):664-8. PubMed ID: 22459398
[TBL] [Abstract][Full Text] [Related]
54. Prospective echocardiographic assessment of androgenic-anabolic steroids effects on cardiac structure and function in strength athletes.
Hartgens F; Cheriex EC; Kuipers H
Int J Sports Med; 2003 Jul; 24(5):344-51. PubMed ID: 12868045
[TBL] [Abstract][Full Text] [Related]
55. Impaired cardiac structure and systolic function in athletes using supra-physiological doses of anabolic androgenic steroids.
Hammoud S; van den Bemt BJF; Jaber A; Kurdi M
J Sci Med Sport; 2023 Oct; 26(10):514-521. PubMed ID: 37758530
[TBL] [Abstract][Full Text] [Related]
56. Biventricular dysfunction and lung congestion in athletes on anabolic androgenic steroids: a speckle tracking and stress lung echocardiography analysis.
D'Andrea A; Radmilovic J; Russo V; Sperlongano S; Carbone A; Di Maio M; Ilardi F; Riegler L; D'Alto M; Giallauria F; Bossone E; Picano E
Eur J Prev Cardiol; 2022 Feb; 28(17):1928-1938. PubMed ID: 34339497
[TBL] [Abstract][Full Text] [Related]
57. The cutaneous bacterial microflora of the bodybuilders using anabolic-androgenic steroids.
Zomorodian K; Rahimi MJ; Taheri M; Ghanbari Asad A; Khani S; Ahrari I; Pakshir K; Khashei R
Jundishapur J Microbiol; 2015 Jan; 8(1):e12269. PubMed ID: 25789120
[TBL] [Abstract][Full Text] [Related]
58. Comparison of Right Ventricle Systolic Function between Long-Term Anabolic-Androgenic Steroid User and Nonuser Bodybuilder Athletes: A Study of Two-Dimensional Speckle Tracking Echocardiography.
Alizade E; Avci A; Tabakcı MM; Toprak C; Zehir R; Acar G; Kargin R; Emiroğlu MY; Akçakoyun M; Pala S
Echocardiography; 2016 Aug; 33(8):1178-85. PubMed ID: 27144714
[TBL] [Abstract][Full Text] [Related]
59. The impact of anabolic androgenic steroids abuse and type of training on left ventricular remodeling and function in competitive athletes.
Ilić I; Djordjević V; Stanković I; Vlahović-Stipac A; Putniković B; Babić R; Nesković AN
Vojnosanit Pregl; 2014 Apr; 71(4):383-9. PubMed ID: 24783419
[TBL] [Abstract][Full Text] [Related]
60. Investigating anabolic-androgenic steroid dependence and muscle dysmorphia with network analysis among male weightlifters.
Scarth M; Westlye LT; Havnes IA; Bjørnebekk A
BMC Psychiatry; 2023 May; 23(1):342. PubMed ID: 37193971
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
